- Efficacy and Safety of MSCs Plus Basiliximab for the Treatment of Steroid-Resistant aGVHD after Haploidentical Stem Cell Transplantation: A Multicenter, Randomized, Open-Label TrialFu, Hai-Xia; Sun, Xueyan; Zhang, Yuanyuan; Han, Tingting; Mo, Xiao-Dong; Lv, Meng; Wang, Fengrong; Yan, Chenhua; Wang, Yu; Kong, Jun; Sun, Yuqian; Chen, Huan; Chen, Yao; Chen, Yu-Hong; Lin, Ren; Gao, Li; Liu, Kaiyan; Zhang, Xiaohui; Zhang, Xi; Liu, Qifa; Huang, Xiaojun; Xu, Lanping64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
- Basiliximab in the Prevention of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major: A Prospective, Multicenter, Open-Label, Randomized Controlled StudyLiu, Rongrong; Wu, Meiqing; Li, Qiaochuan; Liu, Lianjin; Qin, Chunjie; Chen, Hong; Shi, Lingling; Yang, Gaohui; Shi, Zeyan; Li, Zhongqing; Wei, Zhenbin; Liu, Beicai; Fan, Jing; Chen, Yinghua; Zhou, Xuemei; Zhang, Zhongming; Lai, Yongrong; Liu, Qifa64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
- Efficacy of Mesenchymal Stromal Cells for Refractory Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell TransplantationZhao, Ke; Fan, Zhiping; Chen, Xiaoyong; Chang, Yuan; Xuan, Li; Xu, Na; Huang, Fen; Shi, Pengcheng; Lin, Ren; Liu, Hui; Sun, Jing; Xiang, Andy Peng; Liu, Qifa64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
会议论文
A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease
22阅读
